InsidersTradesSigma
Follow the Becton, Dickinson and Company share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €51.6bn. The latest transaction was disclosed on 20 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: RICHARD BYRD. All data is free.
Analysts rate Becton, Dickinson and Company Buy (bullish), based on 12 analysts. Average price target: US$194.42.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Becton, Dickinson and Company es una empresa estadounidense que se especializa en la fabricación de dispositivos médicos, diagnósticos y soluciones de gestión de atención médica. Cotiza en NASDAQ bajo el símbolo BDX.